2005.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 10:08):

Stats
Dagens volum	2.79M
Gjennomsnittsvolum	2.05M
Markedsverdi	14.22B
EPS	HKD0 ( 2024-03-27 )
Last Dividend	HKD0.0700 ( 2023-09-14 )
Next Dividend	HKD0 ( N/A )
P/E	10.89
ATR14	HKD0.00900 (0.19%)

Volum Korrelasjon

Lang: 0.07 (neutral)

Kort: -0.01 (neutral)

Signal:(50.16) Neutral

SSY Group Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

SSY Group Ltd Korrelasjon - Valuta/Råvare

0.00
( neutral )

-0.14
( neutral )

0.00
( neutral )

-0.42
( neutral )

0.00
( neutral )

0.53
( weak )

SSY Group Ltd Økonomi

Annual	2023
Omsetning:	HKD6.46B
Bruttogevinst:	HKD3.49B (53.99 %)
EPS:	HKD0.440

FY	2023
Omsetning:	HKD6.46B
Bruttogevinst:	HKD3.49B (53.99 %)
EPS:	HKD0.440

FY	2022
Omsetning:	HKD6.43B
Bruttogevinst:	HKD3.44B (53.46 %)
EPS:	HKD0.380

FY	2021
Omsetning:	HKD5.36B
Bruttogevinst:	HKD3.17B (59.18 %)
EPS:	HKD0.260

Financial Reports:

No articles found.

SSY Group Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0600 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.160 (N/A)	HKD0.0700 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

SSY Group Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.77 - Increase likely (55.41%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00500	2008-05-23
Last Dividend	HKD0.0700	2023-09-14
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	HKD1.257	--
Avg. Dividend % Per Year	0.00%	--
Score	4.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.77
Div. Directional Score	10.00	--

Next Divdend (Est)
(2024-07-09)

HKD0.0719 Estimate 12.38 %

Dividend Stability

0.50 Below Average

Dividend Score

4.32

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2362.HK	No Dividend Player	2023-06-01	Annually	0.00%
1349.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0393.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
6677.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
1899.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
0927.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
2883.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
1480.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
0551.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.204	1.500	5.92	8.88	[0 - 0.5]
returnOnAssetsTTM	0.110	1.200	6.33	7.59	[0 - 0.3]
returnOnEquityTTM	0.199	1.500	8.91	10.00	[0.1 - 1]
payoutRatioTTM	0.338	-1.000	6.62	-6.62	[0 - 1]
currentRatioTTM	2.03	0.800	4.84	3.87	[1 - 3]
quickRatioTTM	1.587	0.800	5.37	4.30	[0.8 - 2.5]
cashRatioTTM	0.659	1.500	7.45	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.31	-7.96	[0 - 0.6]
interestCoverageTTM	11.88	1.000	6.71	6.71	[3 - 30]
operatingCashFlowPerShareTTM	0.325	2.00	9.89	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0880	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	0.486	-1.500	8.06	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.540	1.000	4.34	4.34	[0.2 - 0.8]
operatingProfitMarginTTM	0.231	1.000	7.39	7.39	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.287	1.000	9.52	9.52	[0.2 - 2]
assetTurnoverTTM	0.540	0.800	9.73	7.79	[0.5 - 2]
Total Score				12.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.80	1.000	9.01	0	[1 - 100]
returnOnEquityTTM	0.199	2.50	9.30	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0880	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	4.80	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.325	2.00	9.89	10.00	[0 - 30]
payoutRatioTTM	0.338	1.500	6.62	-6.62	[0 - 1]
pegRatioTTM	0.560	1.500	9.60	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.149	1.000	8.76	0	[0.1 - 0.5]
Total Score				7.77

SSY Group Ltd

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.